Gold(III) complexes containing N-heterocyclic carbene ligands: thiol "switch-on" fluorescent probes and anti-cancer agents.
about
The mode of action of anticancer gold-based drugs: a structural perspectiveLuminescent Gold(III) Thiolates: Supramolecular Interactions Trigger and Control Switchable Photoemissions from Bimolecular Excited States.Cytotoxicity of Pyrazine-Based Cyclometalated (C^Npz^C)Au(III) Carbene Complexes: Impact of the Nature of the Ancillary Ligand on the Biological Properties.Synthesis of Stable Gold(III) Pincer Complexes with Anionic Heteroatom Donors.Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60.Benzyl-substituted metallocarbene antibiotics and anticancer drugs.Gold(III) complexes in medicinal chemistry.Chemical biology of anticancer gold(III) and gold(I) complexes.Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.Porphyrins Conjugated with Peripheral Thiolato Gold(I) Complexes for Enhanced Photodynamic Therapy.A multi-functional PEGylated gold(iii) compound: potent anti-cancer properties and self-assembly into nanostructures for drug co-deliveryLuminescent bioactive NHC-metal complexes to bring light into cells.Highly cytotoxic bioconjugated gold(I) complexes with cysteine-containing dipeptides.Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication.A luminescent cyclometalated gold(iii)-avidin conjugate with a long-lived emissive excited state that binds to proteins and DNA and possesses anti-proliferation capacity.Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells.A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling.Gold(I) thiolates containing amino acid moieties. Cytotoxicity and structure-activity relationship studies.Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes.Detailed analysis of pro-apoptotic signaling and metabolic adaptation triggered by a N-heterocyclic carbene-gold(I) complex.A binuclear gold(I) complex with mixed bridging diphosphine and bis(N-heterocyclic carbene) ligands shows favorable thiol reactivity and inhibits tumor growth and angiogenesis in vivo.'Auto-click' functionalization for diversified copper(I) and gold(I) NHCs.Insights into the reactivity of gold-dithiocarbamato anticancer agents toward model biomolecules by using multinuclear NMR spectroscopy.Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.A minimalist fluorescent probe for differentiating Cys, Hcy and GSH in live cells.Temperature and pH-tunable fluorescence nanoplatform with graphene oxide and BODIPY-conjugated polymer for cell imaging and therapy.Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase.A structurally-characterized NbCl5-NHC adduct.Luminescent platinum(ii) complexes with self-assembly and anti-cancer properties: hydrogel, pH dependent emission color and sustained-release properties under physiological conditions.Na/K-ATPase as a target for anticancer metal based drugs: insights into molecular interactions with selected gold(iii) complexes.(C^Npz^C)AuIII complexes of acyclic carbene ligands: synthesis and anticancer properties.Development of trackable metal-based drugs: new generation of therapeutic agents.Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets.Turn-On Fluorescence in Tetra-NHC Ligands by Rigidification through Metal Complexation: An Alternative to Aggregation-Induced Emission.Cytotoxic gold(I) N-heterocyclic carbene complexes with phosphane ligands as potent enzyme inhibitors.Stable luminescent iridium(iii) complexes with bis(N-heterocyclic carbene) ligands: photo-stability, excited state properties, visible-light-driven radical cyclization and CO2 reduction, and cellular imaging† †Electronic supplementary information (EChromo-fluorogenic BODIPY-complexes for selective detection of V-type nerve agent surrogatesTransition Metal-Based Photofunctional Materials: Recent Advances and Potential ApplicationsSynthesis, Characterization, Self-Assembly, Gelation, Morphology and Computational Studies of Alkynylgold(III) Complexes of 2,6-Bis(benzimidazol-2′-yl)pyridine DerivativesDeubiquitinases as Anticancer Targets of Gold Complexes
P2860
Q27686705-E0C8AEFE-C7D5-4718-A68B-C0A8FBC47F92Q31143045-7F6813A1-DC1B-4E4A-BFAC-6F077C57CA5BQ33696556-4FA075AA-A88F-40A2-BD47-5781FDFF308FQ34096405-A5900350-2A9C-486D-B9BA-33479CC2A226Q35867952-E0FC6C29-A851-4365-A44E-9E7C8F983B8BQ38207472-E6990682-DFCA-4EB8-BEF4-DB2E4918415BQ38264535-15FA32BE-0234-4873-8534-3BA35D2D816AQ38418786-1B9F330B-8A00-4F5C-AC8E-E724608188A5Q38539464-7D60BEC6-C44D-4374-B853-6AF84EE3C0FDQ38649469-9B1A7061-AEA5-46BC-B059-351F760F6613Q38705760-4A71A8E1-5EA7-41EF-9CF0-1430BCFEAE4BQ38814705-850CD877-E98B-40A1-8E33-9946F1C3133DQ38860140-D4670F2B-B293-44B8-BE15-C155D155DE85Q38883131-D88653DF-0AD5-470D-BB0B-AF5D3B2EFF20Q38884260-80EEA7B5-06D0-438F-9C9D-E9EF969EF6D2Q38914068-BED94DFD-4454-4D77-AACE-5FDBB44E79BEQ38921651-F48CCA39-D79A-4E8F-9A2E-85D9490792FEQ38949131-1BCD7D81-8510-4AC5-A51B-9F8FC2912E9FQ38999673-440C149C-3F2C-4BC8-827F-669151EA522CQ39000649-DA017196-EACA-416E-AA78-CFE36DB0B1C9Q39004496-53C8CF30-37C5-4087-961E-978770A02679Q39008735-6F77543A-D7DE-41CB-9EDF-F83182D87D00Q39095753-CAC4C5F7-52BE-45B9-9E5E-7C39F13358D3Q40444472-A7DD0E45-12B4-4143-99BF-7CAAAEF36280Q41045025-BB2769B0-F35C-48B6-85AE-F9C5CA59AFA4Q43596189-490F23BF-BA5F-487C-9B02-685A84A456F2Q46894751-B0AB9AD9-0EA8-4C51-A0AD-A93AD3CF8D1EQ46915658-E21C83D1-BDDB-49C7-A146-DC20E082C14CQ47167882-9F53ABF1-5F55-4365-9B0F-717930CD4CA9Q48258073-2E19492D-6B5D-4CAE-928B-6DB07BF1515FQ49849146-1140068C-0E3E-4FA6-9334-2B06DA8B9898Q50856412-C2269031-F8BB-493D-885C-65EE4027B80DQ51117652-54BE4AFC-6027-4280-94B5-3DC96349B07DQ51566185-5E24B01E-E1F4-48CA-9394-BDF656ACA738Q52768951-4B75909D-495A-47EE-952D-24FF9CC23686Q55533155-EB9BF8C6-E5FE-452F-B8C8-31C3AA9BB6B7Q57401111-0321D55D-0936-4FE0-8406-E5D223433A91Q58864599-B9BE9521-A76D-4F7E-976D-AEEFE86B4C62Q58864743-74F2D985-1C5E-4229-907D-D6EBEAD7AB68Q58921478-FB49C303-8379-4374-BDCB-B3BC289D80C5
P2860
Gold(III) complexes containing N-heterocyclic carbene ligands: thiol "switch-on" fluorescent probes and anti-cancer agents.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Gold(III) complexes containing ...... probes and anti-cancer agents.
@en
type
label
Gold(III) complexes containing ...... probes and anti-cancer agents.
@en
prefLabel
Gold(III) complexes containing ...... probes and anti-cancer agents.
@en
P2093
P2860
P356
P1476
Gold(III) complexes containing ...... probes and anti-cancer agents.
@en
P2093
Chi-Ming Che
Ching Tung Lum
Stephen Sin-Yin Chui
P2860
P304
P356
10.1002/ANIE.201209787
P407
P50
P577
2013-02-01T00:00:00Z